Weight gain on Mounjaro is more common than you might expect, and it doesn’t necessarily mean the medication isn’t working. Several factors specific to women can stall or temporarily reverse progress, from hormonal shifts and fluid retention to the medication’s own side effects on digestion. Understanding what’s behind the number on your scale can help you figure out whether you’re dealing with a temporary blip or something that needs a different approach.
The Scale Isn’t Always Measuring Fat
One of the most overlooked causes of apparent weight gain on Mounjaro is constipation. The medication slows how quickly food moves through your digestive tract, and when stool sits longer in your intestines, your body absorbs extra water from it. This makes you feel bloated and can add several pounds to the scale that have nothing to do with fat. In clinical studies, more than 5% of people on Mounjaro reported constipation, and the problem got slightly worse at higher doses, with 7% of those on the highest dose experiencing it.
Water retention from hormonal fluctuations, sodium intake, or even the timing of your menstrual cycle can also swing the scale by two to five pounds in a single day. If you’re weighing yourself daily and seeing an uptick around your period or after a salty meal, that’s fluid, not fat gain.
Hunger Creeping Back Before Your Next Dose
Mounjaro reaches peak levels in your body somewhere between 8 and 72 hours after injection, then gradually tapers off over the rest of the week. As drug levels decline, the appetite-suppressing effects weaken and your stomach starts emptying at its normal speed again. This late-week return of hunger, sometimes called “Mounjaro munchies,” can lead to eating significantly more in the last two or three days before your next shot.
At lower doses, this wear-off effect is more noticeable. Some people find that hunger starts returning as early as four or five days after injection. If you’re eating more calories during that window than you realize, it can offset or even outweigh the deficit you built earlier in the week. Tracking what you eat on days five through seven can reveal whether this pattern applies to you.
Weight Loss Plateaus Are Built Into the Process
Weight loss on Mounjaro is not a straight line down. Clinical trial data from the SURMOUNT-1 study shows that most people lose weight fastest in the first three to six months, then hit a plateau. Researchers defined a plateau as losing less than 5% of body weight over any 12-week stretch. For people with a lower starting BMI, that plateau arrived around week 24. For those starting at a higher BMI (class II or III obesity), it came later, around week 36. By week 72, roughly 88 to 90% of all participants had reached their plateau regardless of starting weight.
A plateau doesn’t mean you’re gaining fat. It means your body has adjusted its energy expenditure to match your new, lower weight. You’re burning fewer calories simply because there’s less of you. If you haven’t changed your eating or movement habits to account for this, the scale can stall or even creep upward. Dose titration, where your prescriber gradually increases your dose, is designed partly to push past these stalls, but each new dose level eventually reaches its own equilibrium too.
Muscle Loss Can Slow Your Metabolism
When you lose weight rapidly on any medication, some of that loss comes from lean mass, including muscle. Clinical evaluations from Mounjaro trials found that while most of the weight lost was fat, there was still a measurable reduction in lean mass. Less muscle means a lower resting metabolic rate, which means you burn fewer calories just existing. Over time, this can make the same eating habits that initially produced weight loss start producing weight maintenance or even slight gain.
Resistance training is the most effective way to preserve muscle during weight loss. If you haven’t incorporated strength exercises, your metabolism may have quietly downshifted enough to explain a stall or reversal on the scale. Adequate protein intake also matters. Getting at least 25 to 30 grams of protein per meal helps protect muscle tissue during periods of calorie restriction.
How PCOS Complicates the Picture
Polycystic ovary syndrome affects roughly one in ten women of reproductive age and creates a metabolic environment that actively resists weight loss. About 65 to 70% of women with PCOS have insulin resistance, meaning their bodies produce excess insulin to compensate for cells that don’t respond to it well. High insulin levels promote fat storage and make it harder to burn existing fat, even when you’re eating less.
PCOS also raises androgen levels, which can increase appetite and promote fat accumulation, particularly around the abdomen. Low-grade chronic inflammation, another hallmark of the condition, further worsens insulin resistance and drains energy levels. The result is that women with PCOS may lose weight more slowly on Mounjaro and experience more frequent stalls. Some women notice improvements within weeks, but for many, meaningful changes in weight and metabolic markers take several months to become visible.
Elevated cortisol from chronic stress, which is common alongside PCOS, adds another layer. Higher cortisol is linked to increased abdominal fat storage and greater appetite, creating a hormonal headwind that Mounjaro has to work against.
Menopause and Perimenopause Change the Rules
Declining estrogen levels during perimenopause and menopause accelerate age-related weight gain and shift where your body stores fat, favoring the midsection over the hips and thighs. This hormonal shift also worsens insulin resistance independently of weight, making it harder for your body to respond to Mounjaro’s mechanism of action.
There’s growing evidence that estrogen and Mounjaro may actually work better together. A Mayo Clinic study found that postmenopausal women taking menopausal hormone therapy lost 35% more weight on tirzepatide than women taking the medication alone. Preclinical data suggest estrogen enhances the appetite-suppressing effects of GLP-1, one of the two hormones Mounjaro mimics. If you’re in menopause and not on hormone therapy, your body may be missing that synergistic effect, which could partly explain slower progress or temporary gains.
Practical Steps When the Scale Goes Up
Start by separating real fat gain from the noise. Weigh yourself at the same time each day and look at weekly averages rather than daily numbers. Measurements of your waist, hips, and thighs can reveal fat loss even when the scale is stuck or rising slightly.
Pay attention to what happens in the last two to three days before your next injection. If hunger returns sharply and you find yourself eating more, that late-week window may be where the extra calories are hiding. Planning higher-protein, higher-fiber meals for those days can help bridge the gap.
If you’ve been on the same dose for more than four to six weeks and progress has completely stalled, your body may have adapted to that dose level. This is a normal part of the titration process and worth discussing with your prescriber. For women with PCOS or those going through menopause, addressing the underlying hormonal factors alongside the medication tends to produce better results than relying on Mounjaro alone.
Finally, check for constipation. If you’re not having regular bowel movements, increasing water intake, fiber, and daily movement can make a surprising difference in what the scale shows. Several pounds of retained stool is more common than most people realize, especially on a medication that deliberately slows digestion.